Viewing nowCombinationVdiphine Tablet 5/80 mg
Valsartan 80mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Withers Pharmaceutical Co., Ltd.

MFDS item code 201308495 · Approved 2013.07.30 · Insurance code 660702590
Treatment of essential hypertension not adequately controlled with monotherapy
Patients are in a situation where monotherapy with amlodipine or valsartan alone is insufficient for blood pressure control. In this case, using both medications together can enhance the blood pressure control effect. Thus, combining amlodipine and valsartan helps lower and manage blood pressure more effectively. This combination therapy plays an important role in reducing the risk of complications associated with hypertension. Therefore, this treatment is used to improve blood pressure control.
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using either individual component, switching directly to this medicine may be considered, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 5 mg or valsartan 80 mg. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 5 mg or valsartan 160 mg. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required for patients with mild or moderate renal impairment (creatinine clearance ≥10mL/min). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance <10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; its use is not recommended.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be stopped immediately if pregnancy is confirmed. Patients with allergies to any ingredients in this drug, pregnant or breastfeeding women, patients with severe kidney or liver disease, and certain heart disease patients should not take this medication. Patients with low sodium or fluid levels in the body should stabilize their condition before taking this medication, and blood pressure and physical condition should be carefully monitored during treatment. This drug may increase potassium levels, so when taken with potassium supplements or other medications that raise potassium levels, potassium levels should be checked frequently. Patients with issues with renal blood vessels or those who have recently undergone kidney transplant should use this medication cautiously as it may affect kidney function. If symptoms of angioedema such as swelling of the face, lips, or tongue occur while taking this medication, it should be stopped immediately and a doctor notified. Patients who have heart failure or have had a myocardial infarction are at risk of worsening kidney function or low blood pressure while taking this medication, so regular kidney function testing is important. This medication may cause dizziness or fatigue while driving or operating machinery, so caution is advised. Taking this medication with other antihypertensive drugs, diuretics, anti-inflammatory drugs, etc., may influence its efficacy or side effects, so consultation with a doctor is necessary. It is recommended that pregnant and breastfeeding women do not use this medication, and women planning to become pregnant should consult a doctor before taking it. The safety and efficacy in pediatric patients under 18 years of age have not been sufficiently established, so its use is not recommended. In case of overdose, severe hypotension, dizziness, cardiac function abnormalities, etc., may occur, and medical attention should be sought immediately for appropriate treatment.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, position-related dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, itching, joint swelling, low back pain, arthritis, muscle spasms, lethargy, frequent urination, polyuria, erectile dysfunction, edema, labial edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenic purpura, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disturbances, peripheral neuropathy, hypertonic muscle syndrome, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, voiding dysfunction, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroexcitability, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication is susceptible to air and moisture, so it should be stored in a tightly closed container. It is advisable to maintain the storage temperature between 1 to 30 degrees Celsius. This helps to preserve the efficacy and safety of the drug for a long time.
Dark yellow round film-coated tablet
30 tablets/box [10 tablets/Alu-Alu x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Withers Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.